Heart-Healthy Nutrition Approach for Chronic Kidney Disease Patients

Coronary heart disease in patients with chronic kidney disease.

A Scientific Statement from the American Heart Association in 2003 (1) focused attention on the observation that cardiovascular mortality in patients with chronic kidney disease (CKD) treated by either dialysis or transplantation is markedly higher than in the general population stratified by age, race, and gender. This formalized report updated a concept that was perhaps first enunciated by Sh...

Phosphorus and Nutrition in Chronic Kidney Disease

Patients with renal impairment progressively lose the ability to excrete phosphorus. Decreased glomerular filtration of phosphorus is initially compensated by decreased tubular reabsorption, regulated by PTH and FGF23, maintaining normal serum phosphorus concentrations. There is a close relationship between protein and phosphorus intake. In chronic renal disease, a low dietary protein content s...

Device therapy in heart failure patients with chronic kidney disease.

Heart failure (HF) and chronic kidney disease (CKD) both carry significant risk for sudden cardiac death, hospitalization, and mortality; when combined, however, they markedly increase the risk of morbidity and mortality. Device therapies such as implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy (CRT) are treatments proven to have significant benefit on clinic...

Beta-blockers for coronary heart disease in chronic kidney disease.

BACKGROUND Limited data exist on whether the cardioprotective benefit of beta-blockers is modified by the presence of chronic kidney disease (CKD). METHODS A post hoc analysis of the data from the Bezafibrate Infarction Prevention (BIP) study was performed. CKD was defined according to the Modification of Diet in Renal Disease (MDRD) equation as an estimated glomerular filtration rate (GFR) <...

Vitamin deficiencies in chronic kidney disease